Promoter hypermethylation of RASSF1A and BRCA in serum CFDNA could signify the presence of ovarian cancer with a sensitivity and specificity of 82 and 100%, respectively, using MS-PCR (de Caceres et al., 2004). Here, RASSF1 is linked to ovarian carcinoma.